Redfy Releases Sourcing Guide for Red Light Therapy Equipment
News related to:Redfy · 2 min read
Redfy, a reliable manufacturer of red light therapy for recovery equipment, has released a sourcing guide aimed at helping commercial operators, gym managers, and physical therapy practice owners navigate the complexities of procurement in the photobiomodulation sector. The guide emphasizes the importance of regulatory compliance frameworks, particularly the Medical Device Single Audit Program (MDSAP), for ensuring smooth operations across international markets.
According to the release, Redfy, a brand of Sunplus LED Technology Co., Ltd., operates from an 8,000-square-meter manufacturing facility in Shenzhen, China. The company provides a comprehensive product portfolio, including red light therapy panels, full-body systems, and wearable devices, serving over 100 countries worldwide. With an annual production capacity of 100,000 units and a history dating back to 2014, Redfy supports audits by providing traceable quality documentation and regulatory support for global OEM and ODM projects.
The guide highlights the significance of MDSAP, which represents a global regulatory auditing framework designed to streamline international compliance for medical device manufacturers. MDSAP allows a single regulatory audit conducted by an authorized auditing organization to satisfy the quality management system requirements of five participating national regulatory authorities, including the United States Food and Drug Administration (FDA), Health Canada, Australia's Therapeutic Goods Administration, Brazil's Agencia Nacional de Vigilancia Sanitaria, and Japan's Pharmaceuticals and Medical Devices Agency.
Redfy's commitment to regulatory compliance is further underscored by its structured quality management systems, which operate under ISO 13485:2016 standards and incorporate specific statutory requirements from each participating country. The company's engineering team comprises over 30 technical specialists, ensuring rigorous batch calibration and consistent optical power density using precise spectroradiometers.
The guide also outlines the distinct functional roles of different red light therapy equipment formats. Targeted panels offer adjustable positioning and localized irradiance for specific muscle groups, post-surgical sites, or localized joint inflammation. Full-body therapy pods and therapy beds provide continuous 360-degree light exposure for systemic physical recovery, accelerating metabolic clearance and reducing recovery time between intense training sessions. Ergonomic wearable wraps and flexible targeted care devices offer flexible contouring for specialized care applications, providing versatile treatment options for mobile practitioners and home-care settings.
Redfy's comprehensive product range and technical documentation can be explored on its official website at www.redfycare.com. The company supports enterprise clients in over 108 countries, with a production capacity reaching up to 60,000 units per month, enabling it to meet the demands of both fast-growing brands and large-scale commercial projects.
The global market for red light therapy is expected to exhibit significant growth, with a compound annual growth rate (CAGR) of 13% from 2025 to 2032, reaching a valuation of USD 19.30 Bn by 2032. This growth underscores the increasing demand for advanced red light therapy solutions in various commercial and clinical applications.
By prioritizing certified production standards and regulatory compliance, commercial facility operators, distributors, and health brand owners can secure compliant equipment and establish robust procurement strategies in the photobiomodulation sector.